
Buprigesic 2 Patch In Box
Marketer
Neon Laboratories Ltd
Salt Composition
Buprenorphine (20mg)
Overview Buprigesic 2 Patch In Box
Buprenorphine/naloxone transdermal patches (2 mg/hr) are indicated for managing moderate to severe pain and opioid dependence. They alleviate withdrawal symptoms associated with opioid cessation. Your physician will provide specific instructions for application and usage; adhere strictly to these guidelines for optimal therapeutic effect. Dosage and treatment length vary depending on the indication and clinical response. Consistent use is crucial; do not cease treatment without your doctor's approval. Commonly reported adverse effects include constipation, lightheadedness, somnolence, cephalalgia, and nausea. These may be more pronounced initially or following dose adjustments, typically subsiding with continued use. Persistent or severe adverse reactions necessitate patch removal and immediate medical consultation. Prior to commencing therapy, disclose any pre-existing medical conditions or concurrent medications to your doctor, as drug interactions are possible. Pregnant or lactating individuals require prior medical consultation before initiating treatment.
Uses of Buprigesic 2 Patch In Box
Moderate to severe pain management with morphine, an opioid analgesic.
Major Benefits of Buprigesic 2 Patch In Box:
Administer this medication according to your physician's prescribed dosage and schedule. Always verify the product information on the packaging prior to application. Ensure the application area is clean and completely dry. Peel away the patch's protective covering. Avoid contact with the adhesive surface. Apply the patch to the skin with the adhesive side facing downward, ensuring even contact.
Common Side effects of Buprigesic 2 Patch In Box:
- Headache
- Back pain
- Drowsiness
- Vomiting
- Insomnia (difficulty in sleeping)
- Dizziness
- Abdominal pain
- Weakness
- Sweating
- Constipation
- Withdrawal syndrome
- Infection
- Vertigo
- Inflammation of the nose
- Chills
- Flu-like symptoms
- Nausea
How to use Buprigesic 2 Patch In Box:
Follow your doctor's instructions precisely regarding dosage and treatment length. Always examine the product label prior to application. Apply only to clean, dry skin. Peel away the patch's protective covering, avoiding contact with the adhesive surface. Adhere the patch firmly to the skin, adhesive side down, ensuring even contact.
How Buprigesic 2 Patch In Box works:
Each Buprigesic 2 transdermal patch within its package is a partial opioid agonist. Its mechanism mitigates opioid withdrawal by mimicking the actions of opioid medications. This same action, via targeted brain receptors, also delivers analgesia by altering pain perception and response.
SAFETY ADVICE
AlcoholNone
No known drug interactions.
PregnancyCONSULT YOUR DOCTOR
The use of Buprigesic 2 Patches during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Using Buprigesic 2 patches while breastfeeding is likely inadvisable. Preliminary research indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingNone
No known drug interactions.
KidneyCAUTION
Patients with significant kidney impairment should use Buprigesic 2 Patch In Box cautiously, potentially requiring dosage modification. Physician consultation is advised.
LiverCAUTION
Patients with severe liver dysfunction should use Buprigesic 2 Patch In Box cautiously, potentially requiring dosage modification. A physician's consultation is advised. For individuals with significant hepatic impairment, an alternative pain reliever offering greater dosing flexibility may be preferable.
What if you forget to take Buprigesic 2 Patch In Box :
NA
Facts to Know About Buprigesic 2 Patch In Box
| Label | Value |
|---|---|
| Chemical Category | Phenanthrene Derivatives |
| Developing Habits | . |
| Treatment Category | Neuroscience of the Central Nervous System |
